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ABSTRACT
We have previously shown that distal anterior wall ischemia/reperfusion induces 
gene expression changes in the proximal anterior myocardial area, involving genes 
responsible for cardiac remodeling. Here we investigated the molecular signals of 
the ischemia non-affected remote lateral and posterior regions and present gene 
expression profiles of the entire left ventricle by using our novel and straightforward 
method of 2D and 3D image reconstruction. Five or 24h after repetitive 10min 
ischemia/reperfusion without subsequent infarction, pig hearts were explanted 
and myocardial samples from 52 equally distributed locations of the left ventricle 
were collected. Expressional changes of seven genes of interest (HIF-1α; caspase-3, 
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transcription factor GATA4; myocyte enhancer factor 2C /MEF2c/; hexokinase 2 /
HK2/; clusterin /CLU/ and excision repair cross-complementation group 4 /ERCC4/) 
were measured by qPCR. 2D and 3D gene expression maps were constructed by 
projecting the fold changes on the NOGA anatomical mapping coordinates. Caspase-3, 
GATA4, HK2, CLU, and ERCC4 were up-regulated region-specifically in the ischemic 
zone at 5 h post ischemia/reperfusion injury. Overexpression of GATA4, clusterin and 
ERCC4 persisted after 24 h. HK2 showed strong up-regulation in the ischemic zone and 
down-regulation in remote areas at 5 h, and was severely reduced in all heart regions 
at 24 h. These results indicate a quick onset of regulation of apoptosis-related genes, 
which is partially reversed in the late phase of ischemia/reperfusion cardioprotection, 
and highlight variations between ischemic and unaffected myocardium over time. The 
NOGA 2D and 3D construction system is an attractive method to visualize expressional 
variations in the myocardium.
INTRODUCTION
Metabolism and gene expression patterns are 
changing intensively in the ischemic regions of an 
infarcted heart, but also remote heart regions respond 
to the injury quickly. We have recently shown that both 
acute and chronic ischemia alters the molecular signals 
of the ischemia non-affected, but adjacent regions, termed 
as intrinsic remote conditioning against adverse left 
ventricular (LV) remodeling [1, 2].
Conditioning of the heart against ischemic injury 
is one of the most potent mechanisms to prevent the 
heart from ischemic damage [3–7]. Single or repetitive 
brief intervals of ischemia and reperfusion (r-I/R) 
induce cardioprotective effects against a subsequent 
ischemic insult. The protective effect is characterized 
by two time windows: Early effects last a few hours, 
and are conferred by the rapid release of transmitter 
molecules such as bradykinin and prostaglandins. The 
second window of protection (SWOP) is mainly relying 
on transcriptional regulation, mediated by activation 
of kinases and transcription factors, and subsequent 
effects of proteins generated de novo. The transcriptional 
changes are initiated quickly after r-I/R, and are fully 
effective about one to three days later. Although clinical 
translation of ischemic preconditioning is difficult 
to achieve for practical reasons, elucidation of the 
underlying mechanisms might lead to identification of 
potential modulating agents and molecular targets for the 
development of novel therapeutic strategies [7].
For the investigation of molecular changes in the 
myocardium in heart diseases, precise sampling of tissue 
sections, including documentation, is necessary for 
facilitating understanding of regional variations between 
directly affected and remote tissue [8, 9]. In many rodent 
models and experiments, the entire heart is often analyzed 
as a whole due to its small size. In large animals, the 
affected heart tissue, and usually a randomly selected 
sample of remote heart tissue (often used for “normal” 
control sample) is used for analyses by histology, or for 
gene expression or protein abundance. Exact locations of 
sampling are usually not reported, and the potential impact 
of the sampling locations on the analysis outcome is often 
neglected.
The three-dimensional NOGA® (Biologics Delivery 
Systems, a Johnson & Johnson company, Irwindale, CA, 
USA) mapping system is equipped for simultaneous 
measurement of electrical and mechanical activities of the 
myocardium and distinguishes between viable and non-
viable myocardium [10]. The NOGA and the CARTO 
systems have the same principles to construct 2D and 3D 
real-time display of the myocardial viability, wall motion 
and electrical activity, and are currently the only real 
time 3D imaging technologies available for the clinics. 
In addition the NOGA system can be used for guided 
intramyocardial injections of biologicals.
Here, we show the use of the NOGA system, 
employed as a transcardial mapping in vitro, for precise 
documentation of locations of tissue samples, and for 
creating a map of gene expression levels. By replacing 
the voltage values of the NOGA map by the respective 
fold changes of qPCR quantification, it is possible to 
build color-coded two- or three-dimensional images, 
which aptly visualize spatial gene expression. In order to 
demonstrate the utility of this approach, we determined 
and compared gene expression values in pig hearts with 
repetitive ischemia and reperfusion in a time-window of 
5h and 24h after I/R burden, compared to controls.
RESULTS AND DISCUSSION
Five and 24h after induction of r-I/R by three cycles 
of 10 min percutaneous balloon occlusion/deflation of 
the mid left anterior descending coronary artery, the 
hearts were explanted. For generation of gene expression 
images, 52 tissue samples were collected from the 
explanted pig hearts and utilized the NOGA system for 
defining the precise location of each sample (Figure 1). 
Gene expression for each tissue sample was gathered by 
qPCR. Then, the relative expression values were entered 
in place of the voltage or local activation data in the 
NOGA system. This workflow demonstrates that data 
Oncotarget67229www.impactjournals.com/oncotarget
visualization using the NOGA system is straightforward. 
The intrinsic color coding and 2D and 3D capabilities 
allow for simple and attractive data visualization and 
thus identification of regions with high or low expression 
levels. In particular, the sampling location of the remote 
myocardium is important for the gathered molecular data, 
as for some of the examined genes their expression differs 
significantly within unaffected myocardial tissue sections. 
However, it must be noted that expression in basal tissue 
segments (outer regions in the bulls-eye view) needs to be 
interpreted with some caution, since the tissue composition 
differs (mixture of fibrotic and muscular tissue).
We collected a total of 52 tissue samples for each 
pig heart and compared the individual expression levels of 
seven genes of interest – HIF-1α, caspase-3, transcription 
factor GATA4, myocyte enhancer factor 2C (MEF2c), 
hexokinase 2 (HK2), clusterin (CLU) and excision repair 
cross-complementation group 4 (ERCC4) between control 
animals and pigs that underwent r-I/R (Figure 1). The gene 
selection was based on earlier NGS analyses of ischemic 
and remote tissue areas, and we primarily selected genes 
with currently incompletely elucidated functions in 
ischemic injury (except for HIF-1α) [2]. Two distinct time 
points were investigated; five hours after r-I/R, to examine 
quick transcriptional regulation, and 24 h after r-I/R, to 
gain information on transcriptional changes relevant for 
later, sustained cardioprotection, (SWOP). After filling 
the values obtained by qPCR to the NOGA software, two- 
and three-dimensional visualizations were readily obtained 
(Figure 1).
In ischemic preconditioning, HIF-1α is essential for 
protection from consequent ischemia in both the acute and 
delayed (SWOP) phases of protection [11, 12]. HIF-1α is 
a powerful transcriptional regulator and among its target 
genes are VEGF, EPO, inducible nitric oxide synthase 
(iNOS), and angiopoetin 1 and 2. The regulated genes and 
the functional consequences are to a certain degree cell-
type dependent [13] and include increase of angiogenesis, 
vascular remodeling, and glucose metabolism [12]. In 
pig hearts, HIF-1α was upregulated in ischemic and parts 
of the remote myocardium after 5h (Figure 2). At 24h, 
we observed unchanged HIF-1α expression compared 
to controls in those heart regions, but upregulation in 
the remote zone that had shown unchanged expression 
levels at the earlier time point. This expressional pattern 
indicates an initially strong activation of HIF-1α after r-I/R 
primarily in the directly affected tissue, which recedes 
after 24h. Interestingly, transcriptional upregulation of 
HIF-1α seems to be restricted to the early phase, but it is 
documented that HIF-1α protein is additionally stabilized 
after preconditioning [14]. Thus the downstream targets of 
HIF-1α are active also in the late phase of cardioprotection.
The effector caspase-3 is activated in both the 
intrinsic and extrinsic apoptosis pathways. It is an 
important apoptosis mediator in myocardial infarction., 
Caspase-3 is detected in human serum after an infarct, 
due to escaping into the bloodstream following 
myocardial cell death [15]. Its mRNA levels were 
substantially elevated in ischemia-affected myocardium 
(Figure 2) 5h after r-I/R, but were reduced nearly back 
to baseline levels at the later time point. In remote 
areas, a lower extent of caspase-3 upregulation resulted 
at 5 h and transcription receded back to control levels 
24 h after ischemia. These data indicate that a certain 
degree of apoptosis occurs shortly and temporarily 
after ischemia only in directly affected tissue. We also 
detected a region with increased expression of caspase-3 
in the basal inferoseptal area. Since similar upregulation 
was found for other analyzed genes (Mef2c, GATA4, and 
HIF-1α), this may indicate a local inflammatory process. 
However, expressional data in the basal areas needs to 
be interpreted with some caution. The stress-associated 
transcription factor GATA4 is essential for cardiac gene 
expression in general and modulates adaptive responses 
after injury [16]. It confers regenerative effects and is 
critical for the regenerative capability of neonatal mice 
hearts [17]. Together with transcription factors Mef2c 
and Tbx5 (the combination of the three factors is termed 
GMT), it was reported to be an essential factor in cardiac 
reprogramming [18, 19]. In injured heart tissue, GATA4 
was increasingly upregulated over 24h after r-I/R. 
Similarly to Caspase-3, its upregulation was limited 
to the infarcted area (Figure 3). The time-sequence of 
up regulation suggests that expression of pro-survival 
genes such as GATA4 follow an initial activation of 
pro-apoptotic genes such as caspase-3. In contrast, 
the expression level of the cardiac transcription factor 
MEF2c was found to be largely unchanged (Figure 3). 
This indicates that transcriptional activation of MEF2c 
is not playing a major role in SWOP induced by r-I/R.
Hexokinase-2 is an important enzyme in the glucose 
metabolism, namely the phosphorylation of glucose as one 
of the initiating steps of glycolysis. In addition, HK-2 has 
been shown to be protective against oxidative stress and 
to attenuate the production of ROS [20]. Mitochondrial 
binding of HK-2 promotes cell survival. Decreased 
levels of HK-2 after r-I/R resulted in altered remodeling 
with higher rates of cell death and fibrosis and lower 
angiogenesis [21]. In mice, HK-2 knockdown exaggerated 
cardiac hypertrophy after induction of pressure overload 
[22]. In r-I/R pig hearts, spatial analyses of expression 
showed short-term up-regulation of HK-2 in the ischemic 
area only, with a pronounced down regulation in some 
remote areas 5h after r-I/R and in all heart areas 24h 
after r-I/R (Figure 4 and Supplementary Videos 1-3). 
The quick up regulation after ischemic injury may be 
indicative of an activation of pro-survival signaling, 
and the reduction in all heart areas after 24 h is likely to 
have an important impact of cell energy metabolism, but 
also ROS production, and cardiomyocyte survival, and 
indicates an onset of the molecular processes leading to 
cardiac remodeling.
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The cytoprotective chaperone clusterin/
apolipoprotein J (CLU) is produced and secreted in 
response to stress signals. Its plasma levels are increased 
in several disorders, including neurodegenerative 
diseases and neoplasms, but also atherosclerosis and 
myocardial infarction [23]. Interestingly, CLU was 
recently reported to be associated with survival in 
patients with heart failure [24]. In the myocardium, 
CLU protects against apoptosis, modulates matrix 
metalloproteinase expression and stimulates 
angiogenesis. In a complex with the proteohormon 
leptin, it binds to the leptin receptor, which results in 
Figure 1: Study design and principle of NOGA-guided image-omics. (A) Timeline of the protocol and the three groups. Gene 
expression profiles of the whole LV was determined either without intervention (Group Control), or 5h (Group I/R-5h) or 24h (Group 
I/R-24h) after 3x10 min I/R by repetitive inflation/deflation of an intracoronary balloon placed in the mid part of the porcine left anterior 
descending coronary artery. (B) Method of the myocardial sampling: the explanted heart (without the right ventricular part) was placed on a 
50 mL Falcon tube, and 52 myocardial biopsies were collected with a skin biopsy needle with an equal distribution of the sampling locations 
throughout the entire left ventricle. The biopsy samples were labelled in accordance to the biopsy location, and transferred immediately 
into RNALater. (C) Schematic illustration of the image-omics of the gene expression maps. Using mapping principles of the myocardial 
viability map, sampling locations were detected in in vitro epicardial (surface) NOGA-mapping, using the location point record principles. 
The voltage values recorded by NOGA in the distinct locations were replaced by the respective values of fold changes in gene expressions 
gathered from the excised tissue samples. (D) Delineation of the ischemic and remote areas on the 5h polar map images with transposition 
of the same area onto the control and 24h polar maps. Gene expression values of the corresponding ischemic and remote areas of the 
animals in control, 5h and 24h groups were collectively compared for statistical evaluations.
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Figure 2: Spatiotemporal 2D bulls-eye display of HIF-1α, and caspase-3 gene expression of the entire left ventricle 
after repetitive ischemia/reperfusion (r-I/R). (A) Time-dependent presentation of the different gene expression patterns of HIF-
1α, and caspase-3, of the LV of animals in groups control, I/R-5h and I/R-24h after repetitive (3 times) 10 min I/R without consecutive 
myocardial infarction. Temporary overexpression of HIF-1α and caspase-3 at 5h (red arrow) was detected. Expression levels of HIF-1α 
and caspase-3 were reduced to baseline levels after 24h, except for part of the remote area with HIF-1α upregulation. Pink and blue colors 
represent up-regulation of genes; green represents baseline values, while yellow and red areas show down-regulation of the respective 
genes. (B) Boxplots of values of the ischemic and remote zone. *: p<0.05, **: p>0.01, ***: p<0.001. n.s.: not significant.
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Figure 3: Spatiotemporal 2D bulls-eye display of GATA4 and myocyte enhancer factor 2C (MEF2c) gene expression 
of the entire left ventricle after repetitive ischemia/reperfusion (r-I/R). (A) Time-dependent presentation of the different gene 
expression patterns of GATA4 and MEF2c of the LV of animals in groups control, I/R-5h and I/R-24h after repetitive (3 times) 10 min I/R 
without consecutive myocardial infarction. Mildly increasing upregulation of GATA-4 in the ischemic area at 5 and 24h (red arrows) was 
detected. Only mild upregulation of MEFC2 in the ischemic area was encountered. Pink and blue colors represent up-regulation of genes; 
green represents baseline values, while yellow and red areas show down-regulation of the respective genes. (B) Boxplots of values of the 
ischemic and remote zone. *: p<0.05, **: p>0.01, ***: p<0.001. n.s.: not significant.
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Figure 4: Image-omics (2D and 3D modeling) of the repetitive ischemia/reperfusion (I/R) induced gene expression 
pattern of hexokinase 2 (HK2). (A) Representative 3D (top row) and 2D bulls-eye maps (bottom row) of the left ventricle (LV) 
showing the expression patterns of HK-2. Marked upregulation of HK2 was found in the ischemia-affected apical myocardial region and 
the border zone with concomitant downregulation in the remote myocardial area (yellow arrow) at 5h. At 24h, HK2 expression was severely 
downregulated in all myocardial regions. (B) Boxplots of values of the ischemic and remote zone. *: p<0.05, **: p>0.01, ***: p<0.001.
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transcriptional activation of intracellular pathways 
including the JAK/STAT pathway [25]. We encountered 
an increase in CLU expression already 5h after 
ischemic injury in the apex part of the affected tissue. 
In remote areas, considerable variation was found, with 
downregulation at the earlier time point in one zone and 
a considerable elevation of expression in another part of 
the remote zone 24h after r-I/R (Figure 5). These data 
are an indication that CLU plays a role in restoring cell 
function, cardioprotection and might be an important 
mediator of intrinsic remote conditioning.
The excision repair cross-complementation group 
4 (ERCC4/XPF) gene is a subunit of the ERCC1/XPF 
endonuclease which has a function in repair of DNA 
damage and stress response [26]. It cleaves nucleic acids 
specifically at junctions between double- and single 
stranded DNA and is a component of the machinery 
for nucleotide excision repair, and others. We identified 
ERCC4 to be upregulated after r-I/R in an NGS dataset 
and our spatiotemporal analysis shows that the up 
regulation is focused on the tissue directly affected by 
ischemia (Figure 6). While a deficiency of ERCC1/
ERCC4 has been linked to carcinogenesis and cancer 
progression, its role in the myocardium is currently 
unknown. The upregulation of ERCC4 might be a 
consequence of cell and nucleic acid damage.
Exploiting the 3D reconstruction technology 
of the NOGA endocardial (here epicardial) 
electroanatomical mapping system, we demonstrate a 
new and straightforward methodology with which to 
display gene expression patterns in 2D and 3D, without 
the need for an extensive bioinformatics background 
or training. The image-omics that we present of the 
ischemic preconditioned heart integrates genomic data 
with biomedical imaging. This facilitates exploration 
and visualization of relevant gene expression patterns 
that underlie the SWOP. These data provide biological 
insight into cardioprotective mechanisms that are 
essential for better understanding of the complexity of 
I/R injury.
As reported earlier, the NGS-based analysis of 
global gene expression patterns in ischemic, border, 
and remote zones [2] showed distinct changes of 
several pathways and a number of genes that were 
previously not linked to ischemic preconditioning. 
The gene expression patterns show a quick onset of 
regulatory response after r-I/R in the directly affected 
tissue with up-regulation of genes involved with stress 
response and apoptosis. The more detailed spatial 
expression patterns reported here corroborate the NGS 
results and also highlight the role of intrinsic remote 
conditioning: that remote heart areas (unaffected 
by ischemia) can have varying expression levels of 
genes playing important roles in cardioprotection and 
prevention of adverse left ventricular remodeling. For 
investigating mechanisms such as cardiac remodeling 
on the molecular level, it may thus be advisable to 
harvest tissue sections from a few spots of the remote 
zone. More importantly, we show that the NOGA 
system is particularly useful, yet very facile to use for 
constructing 2D and 3D representations of expression 
patterns. Since externally gathered values of biopsies 
that were taken with the system can be simply entered 
into the software, this approach can likewise be 
employed for any other readout, for example from 
histological analysis or from proteomics data.
Limitation
We have not compared the transcriptomic 
expressions levels of each sampling location between 
control and 5h or 24h samples, because one sample 
of a certain location does not represent the global 
myocardial response to ischemic burden. It is possible to 
quantify segmental gene expression levels by using the 
NOGA 9-segment model, however, this method is not 
standardized. Additionally, the ischemic or borderline 
ischemic myocardial areas cannot be delineated into pre-
defined 9 segments due to overlap of ischemic and non-
ischemic areas.
We used also the 17-segment model for segmental 
gene expression quantification, according to the 
recommendation of the AHA for segmentation of the LV 
by using echocardiography and cardiac MRI. However, 
this method has some limitations. Firstly, the principles 
of the 3D and polar map reconstructions of the MRI and 
NOGA images as well as the point sampling method differ 
[10]. Secondly, analyzing an average of three samples 
in each of the 17 segments precludes a robust statistical 
evaluation. Extended sampling of at least 90 biopsy 
samples, corresponding to 5 or more samples in each 
segment would be required.
CONCLUSION
Using 2D and 3D visualization (2D and 3D 
image-omics) of temporal and spatial gene expression 
maps of the heart, we demonstrate that r-I/R stimuli 
provoke distinct alterations in gene expression 
profiles in different regions of the myocardium. 
We employed a clinically relevant closed-chest pig 
model to highlight transcriptional regulations induced 
by r-I/R. The analysis of multiple tissue samples 
at several time points with the novel methodology 
described herein increases our understanding of 
r-I/R mechanisms. The reported data indicate a short 
term stress response, which is followed by prolonged 
expressional alterations, including transcriptional 
regulators and survival signals, which are essential for 
the second window of cardioprotection after ischemic 
preconditioning in the ischemia affected but also in the 
non-affected myocardial areas.
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Figure 5: Image-omics (2D and 3D modeling) of the repetitive ischemia/reperfusion (I/R) induced gene expression 
pattern of clusterin (CLU). (A) Representative 3D (top row) and 2D bulls-eye maps (bottom row) of the left ventricle (LV) showing 
the expression pattern of CLU. Moderate up-regulation in part of the ischemic zone was detected at 5h (red arrow), with a high degree of 
variation within the remote myocardium. (B) Boxplots of values of the ischemic and remote zone. *: p<0.05, **: p>0.01, ***: p<0.001. 
n.s.: not significant.
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Figure 6: Image-omics (2D and 3D modeling) of the repetitive ischemia/reperfusion (I/R) induced gene expression 
pattern of excision repair cross-complementation group 4 (ERCC4). (A) Representative 3D (top row) and 2D bulls-eye maps 
(bottom row) of the left ventricle (LV) showing the expression pattern of ERCC4. Moderate up-regulation is shown in the ischemic zone at 
both 5h and 24h (red arrows), with little changes between the two time points. (B) Boxplots of values of the ischemic and remote zone. *: 
p<0.05, **: p>0.01, ***: p<0.001. n.s.: not significant.
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MATERIALS AND METHODS
Ethical statement
Animal investigations were carried out in 
accordance with the “Position of the American Heart 
Association on Research Animal Use,” as adopted by the 
AHA on November 11, 1984. The study was approved 
by the Ethics Committee on Animal Experimentation at 
the University of Kaposvar, Hungary. The study design 
is displayed in Figure 1A. The study corresponds to the 
ARRIVE guidelines [27].
Porcine model of repetitive ischemia/reperfusion
Domestic pigs (male, 15 kg, n=20, randomized 
into r-I/R[5h], n=6, r-I/R[24h], n=6, and sham operated 
controls, n=8) underwent cardiac catheterization under 
general anaesthesia. The r-I/R protocol consisted of 
three repetitive cycles of 10 min I/R via percutaneous 
balloon occlusion and deflation in the mid left anterior 
descending coronary artery (LAD) as described 
previously [2].
Briefly, the pigs received an intramuscular injection 
of 12 mg/kg ketamine hydrochloride, 1 mg/kg xylazine 
and 0.04 mg/kg atropine, with inhalation anesthesia with 
isoflurane and O2. After reaching deep anesthesia, pigs 
were intubated and the anaesthesia was continued with 
an anesthetic gas mixture of 1.5-2.5 vol% isoflurane, 
1.6-1.8 vol% O2 and 0.5 vol% N2O. A 6F introduction 
sheath (Medtronic Inc, Minneapolis, MN) was placed 
into the right femoral artery followed by intra-arterial 
administration of unfractionated heparin (200 IU/kg). 
A 6F coronary catheter (Medtronic Inc, Minneapolis, 
MN) was placed into the abdominal aorta and selective 
angiography of the left coronary arteries was performed. 
A guidewire (Medtronic Inc, Minneapolis, MN) and then 
a coronary balloon dilation catheter (2.75 mm diameter, 
12 mm length; Medtronic Inc, Minneapolis, MN), were 
placed into the left anterior descending coronary artery 
below the origin of the second diagonal branch. In the 
r-I/R groups (n=12), coronary occlusion was performed 
with 6 atm inflation pressure. Coronary angiography 
was done by injecting non-ionic contrast media (Takeda, 
Zürich, Switzerland) to monitor occlusion and reperfusion 
of the coronary artery.
Myocardial sampling method
At either 5 h or 24 h after the procedure (Figure 1), 
the animals were sacrificed, and hearts were explanted 
and the right heart part was removed. The entire LV was 
fixed on a 50 mL Falcon tube, and 52 myocardial biopsy 
samples were excised using a skin biopsy needle (Acu-
Punch, Acuderm, Fort Lauderdale, FL). Care was taken 
for equal distribution of the samples throughout the entire 
LV according to anatomical landmarks. The samples were 
uniquely labelled according to a predefined scheme. The 
collected samples were immediately stored in RNALater.
In Vitro NOGA-mapping for image-omics
To enable 2D and 3D displays of the changes in 
gene expression in the LV, the sampling locations were 
determined by in vitro surface NOGA mapping directly 
after sample collection from the explanted heart. The 
NOGA mapping principles and technique have been 
described previously [10]. Briefly, using an ultralow 
magnetic field and a NogaStar® catheter with a magnetic 
tip (Johnson & Johnson, Diamond Bar, California), the 
NOGA system displays the heart showing the location of 
the catheter tip in 3D, and measures the actual electrical 
signals. In contrast with the real-time use of this system 
to illustrate location of the catheter tip in relation with 
viability of that area, for in vitro mapping we used only 
the sampling locations (Figure 1B).
Briefly, the heart (mounted on Falcon tube) with 
the biopsy holes were then put on the angiographic table 
Table 1: Primer sequences and amplicon lengths for qPCR
Gene Forward primer Reverse primer Ampliconlength (bp)
Caspase-3 GGGATTGAGACGGACAGTGG TGAACCAGGATCCGTCCTTTG 136
Clusterin CATGAAGTTCTACGCGCGTG AGTAGAAGGGGGAGCTCTGG 92
ERCC4 ATGGGAAGCACTGACCGAAG GAACACGTCCTGTCGTCACT 114
GATA4 AGAAAACGGAAGCCCAAGAAC CCACACTGCTGGAGTTGCTG 109
HK-2 CAGCAGAACAGCCTGGATGA GGATGGCTTCCTTCAGCAGT 106
MEF2c TAACATGCCGCCATCCGCCC ATCCTCTCGGTCGCTGCCGT 151
GAPDH TCCACCCACGGCAAGTTCCAC ATGTTGGCGGGATCTCGCTCCT 104
HPRT1 CCCAGCGTCGTGATTAGTGA ATCTCGAGCAAGCCGTTCAG 131
PPIA GTCTTCTTCGACATCGCCGT TCCTTTCTCCCCAGTGCTCA 120
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simulating the heart in vivo position, and the heart was 
subjected for in vitro NOGA anatomical surface mapping. 
The NOGA mapping catheter was placed exactly on the 
epicardial surface of each biopsy hole, recording the 
sampling location coordinates in the NOGA system, 
assigning each sample allocation to x, y and z Cartesian, 
and rho and theta polar map coordinates. In this way, the 
heart with sampling holes (NOGA location points) has 
been visualized in the 2D and 3D NOGA imaging map 
(Figure 1C).
qPCR
Tissue sections in RNAlater were stored at -80°C 
until performing RNA isolation. RNA was isolated from 
the samples using column based extraction (RNeasy, 
Qiagen, Germany). RNA concentrations were determined 
using a Nanodrop spectrophotometer (Thermo Fisher) 
and 500 ng of each sample were reverse transcribed 
with random hexamer primers to cDNA according to 
the manufacturer’s protocol (Qiagen). Gene expressions 
were quantified on an Applied Biosystems 7500 Real-
Time PCR System (Life Technologies, USA) using Sybr 
Green Master Mix (Qiagen) with primers listed in Table 1. 
Relative expression values were calculated using the ΔΔCt 
method with normalization to the geometric mean of the 
three reference genes GAPDH, HPRT1, and PPIA. For 
each qPCR run, a calibration curve derived from five 
dilutions (1:8 each) of the same sample was generated for 
normalization across the entire analysis.
Image-omics of the gene expression in 2D and 3D
NOGA-derived quantitative viability values of the 
recorded locations were manually replaced with values 
of fold changes in gene expressions. Since the NOGA 
voltage map cannot display negative values, the minimal 
(maximal down regulation) and maximal (maximal 
up-regulation) values of expression of each gene were 
assigned to a scale of 0-100. The basal posterior region 
value was chosen as basic reference point (value of 
around 20 for almost all genes). All gene expression 
intensities derived from the qPCR were converted to this 
0-100 scale. The color maps thus show downregulation 
(min value of 0) in red, yellow for the reference value 
of the control animals and blue and pink for upregulated 
genes (max count on 100 scale).
Statistics
Myocardial ischemic areas at the 5h polar map 
images separate of each gene maps were delineated, 
and transposed to the polar maps of the corresponding 
control and 24h polar map images. Mean values of the 
gene expression values within and outside this area were 
assigned to ischemic or remote areas, respectively. The 
gene expression of the control, 5h and 24h ischemic 
and remote areas were compared by using ANOVA with 
Holm-Sidac post-hoc tests.
Additionally, the polar maps containing 
the 52 location points with the measured qPCR 
values were divided into 17 segments, similar to 
the echocardiography and cardiac MRI polar map 
segmental display, according to the recommendation 
of the American Heart Association Writing Group on 
Myocardial Segmentation and Registration for Cardiac 
Imaging [28]. The mean values of the expression of 
genes of interest in each 17 segments were calculated 
and the values were compared to the baseline qPCR 
values of the same segment. Since each segment 
contained 3 measured values in average, a direct 
statistical comparison was not justified. However, 
where the difference between the control value and 5h 
or 24h value of the comparative segments was larger 
than the 2xSD of the mean values of both segments, 
this difference was considered biologically relevant 
and displayed in red color in the 17-segment polar map 
display (Supplementary Figures 1-7).
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